Oncological safety, esthetics and surgical safety after skin-sparing mastectomy using Latissimus dorsi reconstruction in patients with mamma carcinoma.
Recruiting
- Conditions
- C50Malignant neoplasm of breast
- Registration Number
- DRKS00003570
- Lead Sponsor
- BrustzentrumDRK-Kliniken Westend
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 120
Inclusion Criteria
Female mamma carcinoma patients treated with skin-sparing mastectomy and reconstruction using the Latissimus dorsi flap. The operation has to be performed at the DRK-Kliniken-Westend or at Dr. Schoenegg's practice.
Exclusion Criteria
Patients who do not speak the german are excluded.
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary endpoint is the oncological safety which will be evaluated by the recurrence and metastasis rate. We will use the patient's records.<br>The observation period is : 1-19 years<br>
- Secondary Outcome Measures
Name Time Method